103 related articles for article (PubMed ID: 16076849)
1. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
[TBL] [Abstract][Full Text] [Related]
2. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
3. Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias.
Naukkarinen J; Nilsson E; Koistinen HA; Söderlund S; Lyssenko V; Vaag A; Poulsen P; Groop L; Taskinen MR; Peltonen L
Circ Cardiovasc Genet; 2009 Oct; 2(5):522-9. PubMed ID: 20031629
[TBL] [Abstract][Full Text] [Related]
4. Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.
Putt W; Palmen J; Nicaud V; Tregouet DA; Tahri-Daizadeh N; Flavell DM; Humphries SE; Talmud PJ;
Hum Mol Genet; 2004 Aug; 13(15):1587-97. PubMed ID: 15175273
[TBL] [Abstract][Full Text] [Related]
5. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of a novel splicing isoform of USF1.
Saito T; Oishi T; Yanai K; Shimamoto Y; Fukamizu A
Int J Mol Med; 2003 Aug; 12(2):161-7. PubMed ID: 12851711
[TBL] [Abstract][Full Text] [Related]
7. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
[TBL] [Abstract][Full Text] [Related]
8. Cooperative activation of lipocalin-type prostaglandin D synthase gene expression by activator protein-2beta in proximal promoter and upstream stimulatory factor 1 within intron 4 in human brain-derived TE671 cells.
Fujimori K; Urade Y
Gene; 2007 Aug; 397(1-2):143-52. PubMed ID: 17574780
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the complex genetics of familial combined hyperlipidemia.
Suviolahti E; Lilja HE; Pajukanta P
Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
[TBL] [Abstract][Full Text] [Related]
10. A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction.
Masotti C; Armelin-Correa LM; Splendore A; Lin CJ; Barbosa A; Sogayar MC; Passos-Bueno MR
Gene; 2005 Oct; 359():44-52. PubMed ID: 16102917
[TBL] [Abstract][Full Text] [Related]
11. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome.
Shoulders CC; Naoumova RP
Trends Mol Med; 2004 Aug; 10(8):362-5. PubMed ID: 15310455
[TBL] [Abstract][Full Text] [Related]
12. Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study.
Choquette AC; Bouchard L; Houde A; Bouchard C; Pérusse L; Vohl MC
Clin Genet; 2007 Mar; 71(3):245-53. PubMed ID: 17309647
[TBL] [Abstract][Full Text] [Related]
13. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary carcinogenesis susceptibility-associated single-nucleotide polymorphisms in K-ras intron 2 affect the binding of factor Gata-6 but not gene expression].
Timofeeva OA; Gorshkova EV; Levashova ZB; Kobzev VF; Filipenko ML; Kaledin VI; Merkulova TI
Mol Biol (Mosk); 2002; 36(5):817-24. PubMed ID: 12391845
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
16. Identifying polymorphisms in the Rattus norvegicus D3 dopamine receptor gene and regulatory region.
Smits BM; D'Souza UM; Berezikov E; Cuppen E; Sluyter F
Genes Brain Behav; 2004 Jun; 3(3):138-48. PubMed ID: 15140009
[TBL] [Abstract][Full Text] [Related]
17. Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1).
Kajiwara M; Terada T; Asaka J; Aoki M; Katsura T; Ikai I; Inui K
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1211-6. PubMed ID: 18845576
[TBL] [Abstract][Full Text] [Related]
18. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
[TBL] [Abstract][Full Text] [Related]
19. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomics on SOX2 orthologs.
Katoh Y; Katoh M
Oncol Rep; 2005 Sep; 14(3):797-800. PubMed ID: 16077994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]